Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
ORIC Pharmaceuticals to Participate in the H.C. Wainwright
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 25, 2023…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq
<!-- Name:DistributionId Value:8741364 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
ORIC Pharmaceuticals to Present at the 41st Annual J.P.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance,…
ORIC Pharmaceuticals Announces Clinical Development
ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with elranatamab in multiple myeloma Jeff Settleman, Ph.D., Chief Scientific Officer, Pfizer Oncology, to join ORIC…